ANI制药公司报告说,尽管利润下降,但收入增加,超过预期。 ANI Pharmaceuticals reports higher revenue, exceeding expectations, despite a drop in profit.

ANI制药公司第一季度利润下降,但报告收入增长43.4%,达到1.971亿美元,超过分析师的预期。 ANI Pharmaceuticals saw a drop in first-quarter profit but reported a 43.4% revenue increase to $197.1 million, exceeding analyst expectations. 该公司提高了2025年财政前景,现在预测收入在7.68亿至7.93亿美元之间,每个份额的收益为6.27至6.62美元。 The company raised its fiscal 2025 outlook, now projecting revenues between $768 million and $793 million, with earnings per share of $6.27 to $6.62. 尽管利润率较低,但在市场前贸易中股票上涨了3.5%。 Despite a lower profit margin, the stock rose 3.5% in pre-market trading.